[ad_1] Just published: An overview of ocular gene therapy… DNA- and RNA-based Gene Therapies in Ophthalmology : International Ophthalmology Clinics #eye #retina #genetherapy #biotech https://t.co/daVyiro6d9 [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] Ophthalmic Procedure Training During COVID-19: Virtual and In-Person Training of the Suprachoroidal Injection Procedure | IOVS | ARVO Journals https://t.co/nRY56y9967 [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
Post hoc Analysis of Clinical Suprachoroidal Injection Experience for Non-infectious Uveitis | IOVS | ARVO Journals https://t.co/HMAJcsegZa https://t.co/5yWdEedxUe
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] Just published: Diabetic Retinopathy in the Aging Population: A Perspective | CIA @DovePress https://t.co/EyB9t38Bsw #eye #diabetes #retina [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1] Pleased to co-edit this summer’s #genetherapy issue of International Ophthalmology Clinics: “DNA- and RNA-based Gene Therapies in Ophthalmology: Preclinical, Clinical and Commercial Considerations” #eye #retina #gene #Biotechnology https://t.co/Dos2g6WtQc [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.
[ad_1]
RT @PrecisionEvolu1: Watch Dr. Anneli Savinainen of @AuraBiosciences presentation Ocular distribution and efficacy after suprachoroidal inj…
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] Published in this month’s Ophthalmology Retina: Macular Anatomy as measured by CST & EZ, often used for treatment decisions & clinical trial endpoints, has limited correlation to vision in RVO, DME, & Uveitic Macular Edema. #eye #retina #diabetes #uveitis https://t.co/HEx2FB70X4 [ad_2] Source by Thomas …
[ad_1] Honored to be named Fellow of the American Society of Retina Specialists, “awarded to members in good standing who have demonstrated consistent commitment to the Society, expertise in the management of vitreoretinal disorders, and the highest ethical and professional standards.” https://t.co/nuwrfKrbTP [ad_2] Source by …
[ad_1]
Longer term Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Neovascular AMD, Diabetic Macular Edema and Retina Vein Occlusion–Related Macular Edema: A Real World Analysis of 130,247 Patient Eyes | IOVS |ARVO Journals https://t.co/umsI90z9M9 https://t.co/t6OZYigDDR
[ad_2]
Source by Thomas Ciulla, MD, MBA
[ad_1] RT @ThomasCiullaMD: Pleased to co-edit this summer’s #genetherapy issue of International Ophthalmology Clinics: https://t.co/SQ6puXq6fb “DN… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.